SenesTech, Inc. Q2 2025 Earnings Recap

SenesTech reported a remarkable second quarter for FY 2025, achieving record revenues and gross profit margins driven by a 94% year-over-year increase in sales of its Evolve Rodent Birth Control solution.

Key Takeaways

• Quarterly revenue hit an all-time high with Evolve sales constituting 83% of total revenues.
• Gross profit margins improved to 65.4%, up from 54.2% year-over-year, signaling strong financial health.
• E-commerce sales surged 78% year-over-year, making up over 50% of total sales, with Amazon as a primary growth driver.
• Significant expansion into brick-and-mortar retail, with a nearly 500% sequential sales increase, bolstered by a partnership with Bradley Caldwell.
• Sales to city and government verticals grew over 500% year-over-year, reflecting strong demand and trial deployments in major urban areas.